Position history for VANGUARD GROUP INC's holdings in ELIEM THERAPEUTICS INC
VANGUARD GROUP INC holds 1.3M shares of CLYM (ELIEM THERAPEUTICS INC), worth $5.4M as of 2025-Q4. The position was increased (++1.9% shares). CLYM represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$5.4M
Current Shares
1.3M
Total Value Change
-$2.4M
Total Shares Change
-184,364
Other major holders of CLYM: RA CAPITAL MANAGEMENT, L.P.
Increased |
| 1.3M |
+1.9% |
| $5.4M |
| 0.0% |
| $4.03 |
27 |
| 2025-Q3 | Decreased | 1.3M | -1.2% | $2.6M | 0.0% | $1.99 | 0 |
| 2025-Q2 | Decreased | 1.3M | -11.4% | $1.7M | 0.0% | $1.18 | 0 |
| 2025-Q1 | Decreased | 1.5M | -0.3% | $1.8M | 0.0% | $1.28 | 0 |
| 2024-Q4 | Decreased | 1.5M | -1.2% | $2.7M | 0.0% | $1.85 | 0 |
| 2024-Q3 | New | 1.5M | - | $7.8M | 0.0% | $4.98 | 38 |